12% OFF
12% OFF Triglimisave 2 15 tab
- 100% genuine
- Free delivery in Roorkee
- Pharmacist checked
Highlights
- Triple-combination diabetes tablet
- Glimepiride, Metformin, Pioglitazone
- Stronger sulfonylurea strength
- Prescription medicine
- Take with a meal
- Watch for low blood sugar
- Periodic blood tests advised
Product information
About
Triglimisave 2 from Eris is a triple-combination tablet for type 2 diabetes that brings together Glimepiride (a sulfonylurea), Metformin (a biguanide) and Pioglitazone (a thiazolidinedione). The higher Glimepiride strength is used when more sugar lowering is needed alongside Metformin and Pioglitazone.
Uses
- Type 2 diabetes not controlled on lower strengths
- Long-term blood sugar management
- Reducing fasting and post-meal sugar
How it works
Glimepiride helps the pancreas release more insulin. Metformin lowers sugar production by the liver and improves how the body uses insulin. Pioglitazone makes muscle and fat cells more sensitive to insulin. The three together tackle high sugar from different angles.
How to take
Take as prescribed by your doctor, usually with or just after a meal to lower the chance of stomach upset and low sugar. Do not skip meals after taking it.
Side effects
- Low blood sugar (shakiness, sweating, hunger)
- Stomach upset, nausea or loose motions
- Weight gain or mild ankle swelling
- Metallic taste
- Vitamin B12 levels may drop on long use
Precautions
Tell the doctor about kidney, liver or heart problems, history of heart failure or bladder issues. Carry sugar or sweets in case of a low. Avoid heavy alcohol. Get periodic kidney, liver and HbA1c tests.
Storage
Store below 25°C in the original strip, away from moisture and direct sunlight. Keep out of reach of children.
The content here is for information only and is not a substitute for professional medical advice. Always consult a doctor or pharmacist before use.
Same composition — other brands
Same salt (Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)) — you choose the brand and price.